Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment

[1] Boykoff N(2009)Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response J Cancer Surviv 3 232-233

[2] Moieni M(2005)A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function Cancer 104 2222-2233

[3] Subramanian SK(2012)Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy J Clin Oncol 30 3578-3587

[4] Jansen CE(2012)Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy J Clin Oncol 30 1080-1086

[5] Miaskowski C(2002)Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients Ann Oncol 13 1387-1397

[6] Dodd M(2009)Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient’s Assessment of Own Functioning Inventory (PAOFI) Psychiatry Res 169 70-74

[7] Dowling G(1997)Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement J Clin Epidemiol 50 441-450

[8] Kramer J(2009)Measuring patient self-reported cognitive function: development of the Functional Assessment of Cancer Therapy - Cognitive Function instrument The Journal of Supportive Oncology 7 W32-W39

[9] Jim HS(2015)Impact of cancer and its treatments on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force symposium and update since 2012 J Pain Symptom Manag 50 830-841

[10] Phillips KM(2011)International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer The Lancet Oncology 12 703-708

[1] Boykoff N(2009)Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response J Cancer Surviv 3 232-233

[2] Moieni M(2005)A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function Cancer 104 2222-2233

[3] Subramanian SK(2012)Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy J Clin Oncol 30 3578-3587

[4] Jansen CE(2012)Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy J Clin Oncol 30 1080-1086

[5] Miaskowski C(2002)Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients Ann Oncol 13 1387-1397

[6] Dodd M(2009)Validity of cognitive complaints in substance-abusing patients and non-clinical controls: the Patient’s Assessment of Own Functioning Inventory (PAOFI) Psychiatry Res 169 70-74

[7] Dowling G(1997)Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement J Clin Epidemiol 50 441-450

[8] Kramer J(2009)Measuring patient self-reported cognitive function: development of the Functional Assessment of Cancer Therapy - Cognitive Function instrument The Journal of Supportive Oncology 7 W32-W39

[9] Jim HS(2015)Impact of cancer and its treatments on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force symposium and update since 2012 J Pain Symptom Manag 50 830-841

[10] Phillips KM(2011)International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer The Lancet Oncology 12 703-708